News - Desert King

Bülow, F.E., et al. A novel thin layer chromatography based method for the quantification of quillaic acid saponins. J Pharm Biomed Anal, 2026 Jun 15, 273:117409. PMID: 41687224

This paper presents a novel, cost-effective thin-layer chromatography (TLC) -based method for quantifying quillaic acid saponins, key bioactive compounds with significant...

Kallenberg, J., et al. Preparing for Tuberculosis Vaccine M72/AS01E Implementation: A Global Demand Forecast and Key Influential Factors. Infect Dis Ther, 2026 Feb 25, PMID: 41739348

This paper provides a comprehensive, data-driven forecast of global demand for the novel M72/AS01E tuberculosis vaccine, which has the potential to significantly reduce T...

Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid O‑d‑Fucosylation

Hudson, G.A., et al. Enzymology and Structural Basis of Glycosyltransferases Involved in Saponin C28 Carboxylic Acid OdFucosylation. JACS Au, 2025 Nov 24, 5(12):6011- 602...

QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants

Hu, Y., et al. QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants. Eur J Med Chem, 2026 Jan 5, 301:118223....

TB vaccine development: monitoring international patent filings to anticipate access challenges

Pignataro, M.F., et al. TB vaccine development: monitoring international patent filings to anticipate access challenges. Front Public Health, 2026 Jan 16, 13:1726153. PMI...

Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice

Quan, Y., et al. Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice. Viruses, 2025 Dec 30, 18(1):53. PMID: 41600818 This study addresses the signifi...

Ferguson, M., et al. Immune persistence and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in adults 50-59 years of age, including at-increased-risk adults: A randomized controlled trial. Hum Vaccin Immunother, 2025 Dec, 21(1):2579335. PMID: 41194599

Respiratory syncytial virus (RSV) is a leading cause of respiratory illness across all age groups, particularly affecting infants, older adults, and individuals with chro...

Rayens, E., et al. Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. Clin Infect Dis, 2025 Dec 24, 81(5):e441-e445. PMID: 40795767

Herpes zoster (shingles) and its complication, herpes zoster ophthalmicus (HZO), are associated with an increased risk of cardiovascular events such as heart attacks and ...